Anxiety Levels Predict Bone Mineral Density in Postmenopausal Women Undergoing Oral Bisphosphonates: A Two-Year Follow-Up

Keyphrases

• Anxiety Level 100%
• Bone Mineral Density 100%
• Postmenopausal Women 100%
• Oral Bisphosphonates 100%
• Hamas 100%
• 2-year Follow-up 100%
• Density Change 41%
• Osteoporosis 16%
• Lumbar Bone Mineral Density 16%
• Body Mass Index 8%
• Depressive Symptoms 8%
• Medical Treatment 8%
• Treatment Response 8%
• Bisphosphonates 8%
• Osteoporotic Fractures 8%
• Alendronate 8%
• Medical Illness 8%
• Dual-energy X-ray Absorptiometry 8%
• Psychological Factors 8%
• Postmenopausal Osteoporosis 8%
• Risedronate 8%
• High Anxiety 8%
• Femoral Bone Mineral Density 8%
• Density Level 8%
• Hamilton Anxiety Rating Scale 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Bisphosphonic Acid Derivative 100%
• Depression 33%
• Disease 33%
• Alendronic Acid 33%
• Fragility Fracture 33%
• Combination Therapy 33%
• Postmenopause Osteoporosis 33%
• Risedronic Acid 33%
• Psychological Aspect 33%